Merit Medical Systems Inc (MMSI) - Net Assets
Based on the latest financial reports, Merit Medical Systems Inc (MMSI) has net assets worth $1.68 Billion USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.86 Billion) and total liabilities ($1.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Merit Medical Systems Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.68 Billion |
| % of Total Assets | 58.66% |
| Annual Growth Rate | 22.71% |
| 5-Year Change | 52.37% |
| 10-Year Change | 218.01% |
| Growth Volatility | 39.17 |
Merit Medical Systems Inc - Net Assets Trend (1989–2025)
This chart illustrates how Merit Medical Systems Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see MMSI market cap overview.
Annual Net Assets for Merit Medical Systems Inc (1989–2025)
The table below shows the annual net assets of Merit Medical Systems Inc from 1989 to 2025. Also explore Merit Medical Systems Inc (MMSI) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.58 Billion | +14.86% |
| 2024-12-31 | $1.38 Billion | +14.76% |
| 2023-12-31 | $1.20 Billion | +5.03% |
| 2022-12-31 | $1.14 Billion | +10.06% |
| 2021-12-31 | $1.04 Billion | +8.47% |
| 2020-12-31 | $958.58 Million | +0.91% |
| 2019-12-31 | $949.94 Million | +1.84% |
| 2018-12-31 | $932.77 Million | +37.92% |
| 2017-12-31 | $676.33 Million | +35.76% |
| 2016-12-31 | $498.19 Million | +6.88% |
| 2015-12-31 | $466.10 Million | +7.09% |
| 2014-12-31 | $435.26 Million | +7.28% |
| 2013-12-31 | $405.71 Million | +6.32% |
| 2012-12-31 | $381.58 Million | +6.86% |
| 2011-12-31 | $357.09 Million | +51.27% |
| 2010-12-31 | $236.07 Million | +7.89% |
| 2009-12-31 | $218.81 Million | +12.61% |
| 2008-12-31 | $194.31 Million | +18.21% |
| 2007-12-31 | $164.37 Million | +8.70% |
| 2006-12-31 | $151.21 Million | +14.14% |
| 2005-12-31 | $132.48 Million | +19.30% |
| 2004-12-31 | $111.05 Million | +25.85% |
| 2003-12-31 | $88.24 Million | +39.19% |
| 2002-12-31 | $63.40 Million | +33.03% |
| 2001-12-31 | $47.66 Million | +37.06% |
| 2000-12-31 | $34.77 Million | +6.34% |
| 1999-12-31 | $32.70 Million | +10.47% |
| 1998-12-31 | $29.60 Million | +12.98% |
| 1997-12-31 | $26.20 Million | +14.41% |
| 1996-12-31 | $22.90 Million | +17.44% |
| 1995-12-31 | $19.50 Million | +10.80% |
| 1994-12-31 | $17.60 Million | +12.10% |
| 1993-12-31 | $15.70 Million | +18.05% |
| 1992-12-31 | $13.30 Million | +82.19% |
| 1991-12-31 | $7.30 Million | +143.33% |
| 1990-12-31 | $3.00 Million | +200.00% |
| 1989-12-31 | $1.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Merit Medical Systems Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 82473000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $824.03 Million | 52.01% |
| Common Stock | $763.91 Million | 48.22% |
| Other Comprehensive Income | $-3.64 Million | -0.23% |
| Total Equity | $1.58 Billion | 100.00% |
Merit Medical Systems Inc Competitors by Market Cap
The table below lists competitors of Merit Medical Systems Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zalando SE
XETRA:ZAL
|
$5.15 Billion |
|
Bank of Ayudhya Public Company Limited
F:NVAU
|
$5.15 Billion |
|
LB Group Co Ltd
SHE:002601
|
$5.15 Billion |
|
Ho Chi Minh City Development Joint Stock Commercial Bank
VN:HDB
|
$5.15 Billion |
|
Porsche Automobil Holding SE
XETRA:PAH3
|
$5.14 Billion |
|
Angel Yeast Co Ltd
SHG:600298
|
$5.14 Billion |
|
CCC Intelligent Solutions Holdings Inc. Common Stock
NASDAQ:CCCS
|
$5.14 Billion |
|
Jinan Shengquan Group Share Holding Co Ltd
SHG:605589
|
$5.14 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Merit Medical Systems Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,379,359,000 to 1,584,303,000, a change of 204,944,000 (14.9%).
- Net income of 128,489,000 contributed positively to equity growth.
- New share issuances of 28,213,000 increased equity.
- Other comprehensive income increased equity by 15,765,000.
- Other factors increased equity by 32,477,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $128.49 Million | +8.11% |
| Share Issuances | $28.21 Million | +1.78% |
| Other Comprehensive Income | $15.77 Million | +1.0% |
| Other Changes | $32.48 Million | +2.05% |
| Total Change | $- | 14.86% |
Book Value vs Market Value Analysis
This analysis compares Merit Medical Systems Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.29x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1196.39x to 3.29x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1989-12-31 | $0.07 | $86.14 | x |
| 1990-12-31 | $0.26 | $86.14 | x |
| 1991-12-31 | $0.36 | $86.14 | x |
| 1992-12-31 | $0.61 | $86.14 | x |
| 1993-12-31 | $0.70 | $86.14 | x |
| 1994-12-31 | $0.74 | $86.14 | x |
| 1995-12-31 | $0.83 | $86.14 | x |
| 1996-12-31 | $0.91 | $86.14 | x |
| 1997-12-31 | $1.02 | $86.14 | x |
| 1998-12-31 | $1.12 | $86.14 | x |
| 1999-12-31 | $1.24 | $86.14 | x |
| 2000-12-31 | $1.27 | $86.14 | x |
| 2001-12-31 | $1.60 | $86.14 | x |
| 2002-12-31 | $1.93 | $86.14 | x |
| 2003-12-31 | $2.61 | $86.14 | x |
| 2004-12-31 | $3.21 | $86.14 | x |
| 2005-12-31 | $3.81 | $86.14 | x |
| 2006-12-31 | $4.28 | $86.14 | x |
| 2007-12-31 | $4.66 | $86.14 | x |
| 2008-12-31 | $5.44 | $86.14 | x |
| 2009-12-31 | $6.12 | $86.14 | x |
| 2010-12-31 | $6.56 | $86.14 | x |
| 2011-12-31 | $8.99 | $86.14 | x |
| 2012-12-31 | $8.96 | $86.14 | x |
| 2013-12-31 | $9.46 | $86.14 | x |
| 2014-12-31 | $10.03 | $86.14 | x |
| 2015-12-31 | $10.47 | $86.14 | x |
| 2016-12-31 | $11.10 | $86.14 | x |
| 2017-12-31 | $13.50 | $86.14 | x |
| 2018-12-31 | $17.30 | $86.14 | x |
| 2019-12-31 | $16.89 | $86.14 | x |
| 2020-12-31 | $17.29 | $86.14 | x |
| 2021-12-31 | $18.13 | $86.14 | x |
| 2022-12-31 | $19.84 | $86.14 | x |
| 2023-12-31 | $20.60 | $86.14 | x |
| 2024-12-31 | $23.24 | $86.14 | x |
| 2025-12-31 | $26.20 | $86.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Merit Medical Systems Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.11%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.48%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.70x
- Recent ROE (8.11%) is above the historical average (6.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1989 | -40.00% | -28.57% | 0.88x | 1.60x | $-500.00K |
| 1990 | 3.33% | 2.27% | 1.19x | 1.23x | $-200.00K |
| 1991 | 17.81% | 12.38% | 1.12x | 1.29x | $570.00K |
| 1992 | 9.02% | 6.52% | 1.12x | 1.23x | $-130.00K |
| 1993 | 11.46% | 7.09% | 1.24x | 1.31x | $230.00K |
| 1994 | 7.43% | 3.90% | 1.23x | 1.54x | $-450.00K |
| 1995 | 6.22% | 2.82% | 1.23x | 1.79x | $-730.00K |
| 1996 | 9.78% | 4.36% | 1.21x | 1.85x | $-50.00K |
| 1997 | 3.10% | 1.32% | 1.34x | 1.76x | $-1.78 Million |
| 1998 | 8.59% | 3.65% | 1.35x | 1.74x | $-410.00K |
| 1999 | 9.79% | 4.10% | 1.08x | 2.21x | $-70.00K |
| 2000 | 2.38% | 0.90% | 1.28x | 2.05x | $-2.65 Million |
| 2001 | 14.13% | 6.47% | 1.56x | 1.40x | $1.97 Million |
| 2002 | 17.84% | 9.73% | 1.48x | 1.24x | $4.97 Million |
| 2003 | 19.60% | 12.72% | 1.27x | 1.22x | $8.47 Million |
| 2004 | 16.15% | 11.84% | 1.08x | 1.26x | $6.83 Million |
| 2005 | 11.91% | 9.47% | 1.03x | 1.22x | $2.53 Million |
| 2006 | 8.13% | 6.45% | 1.04x | 1.21x | $-2.82 Million |
| 2007 | 9.48% | 7.50% | 1.04x | 1.22x | $-848.80K |
| 2008 | 10.67% | 9.13% | 0.98x | 1.19x | $1.30 Million |
| 2009 | 10.30% | 8.75% | 0.95x | 1.24x | $649.10K |
| 2010 | 5.28% | 4.20% | 0.80x | 1.57x | $-11.15 Million |
| 2011 | 6.45% | 6.41% | 0.80x | 1.25x | $-12.66 Million |
| 2012 | 5.17% | 5.00% | 0.56x | 1.85x | $-18.45 Million |
| 2013 | 4.08% | 3.69% | 0.62x | 1.80x | $-24.00 Million |
| 2014 | 5.28% | 4.51% | 0.68x | 1.72x | $-20.55 Million |
| 2015 | 5.11% | 4.39% | 0.70x | 1.67x | $-22.81 Million |
| 2016 | 4.04% | 3.33% | 0.64x | 1.89x | $-29.70 Million |
| 2017 | 4.07% | 3.78% | 0.65x | 1.64x | $-40.11 Million |
| 2018 | 4.50% | 4.76% | 0.54x | 1.74x | $-51.26 Million |
| 2019 | 0.57% | 0.55% | 0.57x | 1.85x | $-89.54 Million |
| 2020 | -1.03% | -1.02% | 0.58x | 1.74x | $-105.70 Million |
| 2021 | 4.66% | 4.51% | 0.65x | 1.59x | $-55.53 Million |
| 2022 | 6.51% | 6.47% | 0.69x | 1.45x | $-39.92 Million |
| 2023 | 7.85% | 7.51% | 0.54x | 1.93x | $-25.79 Million |
| 2024 | 8.73% | 8.87% | 0.56x | 1.75x | $-17.58 Million |
| 2025 | 8.11% | 8.48% | 0.56x | 1.70x | $-29.94 Million |
Industry Comparison
This section compares Merit Medical Systems Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,046,585,171
- Average return on equity (ROE) among peers: -92.85%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Merit Medical Systems Inc (MMSI) | $1.68 Billion | -40.00% | 0.70x | $5.14 Billion |
| Akoya Biosciences Inc (AKYA) | $7.59 Million | -728.97% | 15.46x | $64.44 Million |
| Align Technology Inc (ALGN) | $1.25 Billion | 31.94% | 0.64x | $10.77 Billion |
| AngioDynamics Inc (ANGO) | $542.60 Million | 3.01% | 0.30x | $639.00 Million |
| AptarGroup Inc (ATR) | $1.98 Billion | 12.30% | 1.09x | $7.66 Billion |
| AtriCure Inc (ATRC) | $-27.33 Million | 0.00% | 0.00x | $2.21 Billion |
| Avinger Inc (AVGR) | $15.59 Million | -303.70% | 2.47x | $1.52 Million |
| Avantor Inc (AVTR) | $-3.05 Billion | 0.00% | 0.00x | $9.19 Billion |
| Azenta Inc (AZTA) | $313.81 Million | 8.67% | 1.14x | $1.45 Billion |
| Baxter International Inc (BAX) | $8.47 Billion | 31.37% | 2.34x | $12.16 Billion |
| Becton Dickinson and Company (BDX) | $959.80 Million | 16.88% | 1.15x | $48.93 Billion |
About Merit Medical Systems Inc
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires… Read more